نتایج جستجو برای: menstrual blood stem cell

تعداد نتایج: 2341286  

Journal: :modares journal of medical sciences: pathobiology 2013
mahmood bozorgmehr amir hassan zarnani ali sheikhian mojdeh salehnia ali jabbari arfaee

objective: menstrual blood stromal stem cells (mbscs) share some phenotypic and functional similarities with mesenchymal stem cells (mscs). mscs are shown to inhibit either the function or generation of different immune cells, including dendritic cells (dcs). however, data regarding mbscs’ potential effects on immune system cells are elusive. here, we examine whether mbscs affect the generation...

Journal: :The open stem cell journal 2011
Julie G Allickson Anthony Sanchez Natalie Yefimenko Cesar V Borlongan Paul R Sanberg

We are in the beginning of the era of regenerative medicine and many researchers are testing adult stem cells to be used for tissue repair and regeneration in the human body. Many adult stem cells have been discovered since the late 1990's with more recently a novel adult stem cell described in menstrual blood. The menstrual blood is derived from shedding of the endometrial lining, specifically...

Journal: :world journal of plastic surgery 0
hossein faramarzi department of infectious diseases, larestan school of medical sciensce, larestan, iran davood mehrabani stem cell and transgenic technology research center, shiraz university of medical science, shiraz, iran; maryam fard department of anatomical sciences, qazvin university of medical sciences, qazvin, iran maryam akhavan department of anatomical sciences, qazvin university of medical sciences, qazvin, iran sona zare skin and stem cell research center, tehran university of medical sciences, tehran, iran shabnam bakhshalizadeh department of anatomical sciences, school of medicine, tehran university of medical sciences, tehran, iran

background menstrual blood-derived stem cells (menscs) are a novel source of stem cells that can be easily isolated non-invasively from female volunteered donor without ethical consideration. these mesenchymal-like stem cells have high rate of proliferation and possess multi lineage differentiation potency. this study was undertaken to isolate the menscs and assess their potential in differenti...

2018
Yanli Liu Rongcheng Niu Fen Yang Yan Yan Shengying Liang Yuliang Sun Ping Shen Juntang Lin

Successful isolation of human endometrial stem cells from menstrual blood, namely menstrual blood-derived endometrial stem cells (MenSCs), has provided enticing alternative seed cells for stem cell-based therapy. MenSCs are enriched in the self-regenerative tissue, endometrium, which shed along the periodic menstrual blood and thus their acquisition involves no physical invasiveness. However, t...

Journal: :مجله علوم اعصاب شفای خاتم 0
mohammad reza khojasteh medicine faculty, islamic azad university, mashhad branch, mashhad, iran aida javad zadeh medicine faculty, islamic azad university, mashhad branch, mashhad, iran ali shariat razavi medicine faculty, islamic azad university, mashhad branch, mashhad, iran sajad sahab negah a. department of neuroscience, mashhad university of medical sciences, mashhad, iran b. shefa neuroscience research center, khatam alanbia hospital, tehran, iran

blood brain barrier (bbb) is a specialized non fenestrate barrier that formation by the endothelial cells and controls the transportation of the cells and molecules in to the brain. reducing in function of bbb is one of disruptions in neurological diseases like multiple sclerosis. endothelial progenitor cell (epc) help to the bbb to control the diapedesis of inflammatory cells & molecules in to...

Journal: :international journal of hematology-oncology and stem cell research 0
amir ali hamidieh hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, dr. shariati hospital, tehran, iran kamran alimoghaddam hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, dr. shariati hospital, tehran, iran mohammad jahani hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, dr. shariati hospital, tehran, iran arash jalali hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, dr. shariati hospital, tehran, iran afsaneh alimohammadi hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, dr. shariati hospital, tehran, iran ardeshir ghavamzadeh hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, dr. shariati hospital, tehran, iran

introduction: neuroblastoma is the most common extracranial solid tumor in children, accounting for 8% to 10% of all childhood cancers. significantly, autologous transplantation appeared to have the largest impact on survival for the high risk subset of patients, such as those with n-myc amplified metastatic disease diagnosed after age 2 years. patients and methods: this study includes high ris...

Journal: :international journal of hematology-oncology and stem cell research 0
saeed mohammadi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran ashraf malek mohammadi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran mohsen nikbakht hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran amir hossein norooznezhad hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran kamran alimoghaddam hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran ardeshir ghavamzadeh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran

peripheral blood stem cell transplantation (pbsct) is an effective treatment for hematological malignancies. mobilization of peripheral blood progenitor cells performs in different ways among transplantation centers. forceful mobilization schedules are comprised of growth factor alone, chemotherapy along with growth factor and also, a newly combination of novel agent such as plerixafor with any...

Journal: :journal of biotechnology and health sciences 0
mohammadhossein ahmadi blood transfusion research center, high institute for research and education in transfusion medicine, tehran, ir iran ehteramolsadat hosseini blood transfusion research center, high institute for research and education in transfusion medicine, tehran, ir iran; blood transfusion research center, high institute for research and education in transfusion medicine, iranian blood transfusion organization building, p. o. box: 146651157, tehran, ir iran. tel: +98-9121599012, fax: +98-2188628741 ali akbar pourfathollah professor of immunology, tarbiat modares university, tehran, ir iran mehran ghasemzadeh blood transfusion research center, high institute for research and education in transfusion medicine, tehran, ir iran gharib karimi blood transfusion research center, high institute for research and education in transfusion medicine, tehran, ir iran

conclusions our results suggested that cb-nk cells progenitors could proliferate and differentiate on feeder layer of amnion membrane mscs in combination with specific cytokines to produce nk cells for immunotherapy. results combination of cytokines and msc layer yielded significant fold expansion in comparison with cytokines without feeder conditions (day 7: 5.2 ± 1.12 and 2 ± 0.78, respective...

One of the readily available sources of mesenchymal stem cells (MSCs) is menstrual blood-derived stem cells (Men-SCs), which exhibit characteristics similar to other types of MSCs. This study was performed to determine the growth kinetics, plasticity, and characterization of Men-SCs in women. During spring 2014 in the southern Iranian city of Shiraz, menstrual blood (5 mL) was obtained from 10 ...

Journal: :acta medica iranica 0
a. ghavamzadeh m. iravani m. jahani b. bahar a. mousavi s. gholibeikian

in this center, from 1991 to 2002, 89 chronic myelogenous leukemic (cml) patients, age ranging between 8-48 years with a median age of 29, underwent hematopoietic stem cell transplantation. eighty-eight patients were in the first chronic phase of disease. twenty-three patients received bone marrow transplantation (bmt) and 66 patients received peripheral blood stem cell transplantations (pbsct)...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید